Ernest Gallo Clinic and Research Center At the University of California, San Francisco
About Research & Faculty News Careers & Training Institute for Molecular Neuroscience NIAAA Center (ACTG) Contact Search

NEWS

7/25/2012 - Increasing Dopamine in Frontal Cortex Decreases Impulsive Tendency, UCSF-Gallo Scientists Find

7/11/2012 - Gallo Research Center to Lead $15 Million U.S. Army-Funded National Research Program

5/2/2012 - Anti-smoking Drug Decreases Alcohol Consumption in Heavy-drinking Smokers

1/11/2012 - UCSF Gallo scientists show that drinking releases brain endorphins

12/6/2011 - Jennifer Whistler, PhD, receives $825,500 research award from Novo Nordisk

11/3/2011 - FDA-Approved Drug Might Prevent Relapse In Male Alcoholics

9/26/2011 - Wilbrecht Receives Presidential Early Career Award

9/12/2011 - Enzyme Might Be Target for Treating Smoking, Alcoholism at Same Time

1/11/2011 - FDA-Approved Drug Shows Promise as Alcoholism Treatment

11/7/2010 - Dr. Raymond L. White Awarded the Public Service Medal of the Government of Singapore

11/3/2010 - Gallo Research Shows New Compounds May Treat Both Alcohol and Cigarette Addiction

11/1/2010 - Gallo Center Researchers Find Potential New Drug Target for Alcohol Addiction

9/1/2010 - Biochemical Pathway May Link Addiction, Compulsive Eating

Gallo Researchers Use Pulses of Light to Change Mouse Minds

Source: UCSF press release
Date: August 19, 2012

A Gallo Center research team led by Linda Wilbrecht, PhD, has demonstrated that complex decision-making in mice can be biased with pulses of light. The pulses directly stimulate neural pathways in the dorsal medial striatium, a brain region involved in decision-making and addiction.

In a study published on August 19, 2012 in Nature Neuroscience, co-authors Lung-Hao Tai, PhD and Moses Lee trained mice to seek a water reward by making one of two choices. The mice indicated their decision by poking their noses into a central port, and then moving either to the left or right to obtain the water. To make the task challenging for the mice, water was delivered with only 75 percent probability after a correct choice, and the side that delivered water was switched after a block of seven to 23 trials on each side. Based on these complicated rules, the mice had to remember where they had been and what had happened in the prior two to three trials in order to correctly predict which side to choose.

Once mice learned the task, the scientists sought to alter how they weighed the evidence provided by their memory of past trials. The researchers did this by altering activity in the dorsal striatum. The team focused on two circuits—the dopamine D1 receptor expressing “direct pathway,” which is thought to facilitate action, and the dopamine D2 receptor expressing “indirect pathway,” which is thought to inhibit competing actions. “Previous studies have shown that increased activity in the dorsal striatum can be seen just prior to a choice, suggesting that the decision process may, in part, be controlled by this brain region,” said Wilbrecht. The researchers used a technique called optogenetics to stimulate the D1 or D2 pathway with a few short pulses of blue light during a half-second period just before the mouse made the decision to go left or right. These few pulses caused the striatal neurons to fire a few extra action potentials in response to the light, adding to the activity of the brain as it made a decision.

Wilbrecht and her team found that stimulating the D1 pathway biased choices toward the side opposite that of the side of the brain being stimulated, while stimulating the D2 pathway biased choices toward the same side as that being stimulated. The size of the effect varied in direct proportion to the rate and number of light pulses that were administered—the more pulses, the larger the effect on choice.

“The point of trying to shift the mouse’s decision-making patterns with light was to learn how the mouse brain uses activity in these different cell types to weigh the value of competing choices,” explained Wilbrecht. “These data help us understand how a decision to make an action occurs at the cellular level.”

Discussing the experiment’s relevance to addiction research, Wilbrecht noted, “Addiction is a disease of decision-making. We can’t really understand addiction if we don’t understand how the brain assesses value and makes decisions. If it’s broken, we need to know how it works in order to fix it.”

CONTACT US
5858 Horton Street, Suite 200
Emeryville, CA 94608
Phone: (510) 985-3109

Clinical Studies l Webmail